ÂÜÀòÂÒÂ×

Dee is Co-Founder and CEO for Switch Therapeutics. She received her PhD from Caltech and MBA from Stanford University Graduate School of Business. Before Switch, Dee was the Chief Business Officer at XOMA. Prior to that, she served as Vice President, Corporate Development at Forty Seven, Inc., where she managed business development, strategy and company financings. Earlier in her career, she was a venture capitalist at The Column Group and Longitude Capital. As an investor, she has experience in alternative financing strategies, such as royalty monetization, in addition to formation and management of portfolio companies.